ClinicalTrials.gg
RecruitingNCT05283369Updated May 7, 2024

Changes in Motor Function and Brain Connectivity on Subacute Stroke Patients, Associated With Videogame Therapy

An interventional study of Videogame therapy and Conventional therapy in Ischemic Stroke, sponsored by Universidad Nacional Autonoma de Mexico. Recruiting at 1 site in Mexico. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2024-05-07.

Sponsored by Universidad Nacional Autonoma de Mexico · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started Dec 2022; still recruiting 3 years 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The use of interactive applications associated with movement sensors has begun to spread as an option for the reinforcement of physical rehabilitation therapies in patients with acquired motor disabilities as a consequence of some neurological damage, due to their portability and the relative autonomy that they grant to the patient. However, the results of its effectiveness and impact continue to be discreet compared to traditional therapy. The present study aims to explore possible changes in motor function and in the brain's functional connectivity through resting-state functional Magnetic Resonance Imaging (rs-fMRI), for subacute ischemic stroke outpatients, associated with occupational therapy using interactive applications as a therapeutic complement, comparing with patients on conventional therapy, for which a randomized pilot study with an experimental group and a matched control group will be carried out. The intervention will consist of the application of a virtual rehabilitation program in addition to physical therapy for the experimental group, while the control group will receive conventional physical therapy. Before and after the said intervention, standardized tests will be applied to evaluate the mobility, motor function, and cognitive impairment of the participants. The results obtained will be subject to statistical analysis.

Read the detailed description

This intervention protocol aims to validate four interactive applications for telerehabilitation, as an effective therapeutic complement for the rehabilitation of patients with subacute ischemic stroke compared to conventional rehabilitation when it is administered in the subacute stage (weeks 2 to 16 after stroke).

The intervention contemplates first a phase of application of standardized tests in the rehabilitation unit of the National Institute of Neurology and Neurosurgery (INNN) in Mexico City, to determine, among other things, if the patient meets the established inclusion criteria. Patients who meet these criteria will be randomly assigned to the control or experimental group.

In the same INNN, standardized tests will be applied to record their motor and cognitive capacity at the beginning of the protocol. Patients assigned to the experimental group will be given training for using the video games at home. The trained staff of the Laboratory for Research and Development of Interactive Applications for Neurorehabilitation (LANR) will be responsible for the virtual rehabilitation program. Regarding the dose and frequency of treatment, all patients, both in the control and experimental groups, will receive the same number of physical therapy sessions in the INNN rehabilitation unit. Patients in the experimental group will commit to doing additional video game therapy, consisting of 300 minutes distributed over at least 5 days per week for 2 months (8 weeks) for a total of 40 effective days of performing the therapy. Once a week they must send a video showing how they are performing all the exercises and every 15 days they will be scheduled for a supervised virtual therapy session at the INNN, to check that the exercises are being performed correctly. Patients in the control group will receive the prescribed sessions of conventional occupational therapy for 8 weeks.

Some of the patients assigned to the control group and the experimental group will be summoned to undergo functional magnetic resonance imaging in the National Institute of Rehabilitation (INR), which will serve as a reference to assess possible changes in functional connectivity once the treatment is finished.

In the case of the experimental group, four interactive applications will be tested, each with a different sensor and virtual environment, as well as its own therapeutic objective, these applications are part of the National Autonomous University of Mexico (UNAM) virtual rehabilitation platform.

02

Conditions studied

  • Ischemic Stroke

Keywords

  • Hemiparesis
  • Subacute
  • virtual rehabilitation
  • Functional Magnetic Resonance Imaging
  • videogames
03

In context

Ischemic Stroke

2,612 studies on the registry are indexed under Ischemic Stroke; 971 are open to participants now.

This study's planned enrollment of 60 is below the median of 120 across 1,776 interventional studies indexed under Ischemic Stroke.

Browse Ischemic Stroke studies →

Lead sponsor

Universidad Nacional Autonoma de Mexico is the lead sponsor of 28 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Upper extremity hemiparesis caused by ischemic stroke on its dominant side or not
  • In the subacute phase. From 2 to 16 weeks of ischemic stroke event
  • Fugl-Meyer Upper Extremity > 15
  • No previous stroke

Exclusion criteria

Exclusion Criteria:

  • Token Test \< 17. Inability to understand verbal instructions
  • Instability of the shoulder, elbow, or wrist joints
  • Severe concomitant medical problems such as congestive heart failure or seizures
  • Anosognosia
  • Severe aphasia
  • Hemispatial neglect
  • Visual impairments that are not corrected with glasses
  • Uncompensated hearing impairment
  • Patients receiving concomitant therapies
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Videogame therapy

    Participants will receive conventional physical therapy, plus 300 minutes of videogame in-home therapy a week, for 8 weeks.

    Device: Videogame therapy

  • Active comparator
    Conventional therapy

    Participants will receive conventional physical therapy, plus conventional occupational therapy, as prescribed by the doctor for 8 weeks.

    Other: Conventional therapy

Interventions

  • DeviceVideogame therapy

    The usual dose of conventional physical therapy, plus 300 minutes a week of in-home videogame therapy for 8 weeks.

  • OtherConventional therapy

    The usual dose of physical and occupational therapy, for 8 weeks.

06

What researchers measure

Primary outcomes

  1. Fugl-Meyer Upper Extremity Test (FMUE)

    The Fugl-Meyer test for Upper extremity. To assess level of motor disability

    Time frame: Baseline, 8 Weeks

Secondary outcomes

  1. Wolf Motor Function Test (WMFT)

    The Wolf Motor Function Test. To assess motor skill level

    Time frame: Baseline, 8 Weeks

  2. Chedoke Arm and Hand Activity Inventory (CAHAI-7)

    The Chedoke Arm and Hand Activity Inventory 7 tasks Test. To assess motor function

    Time frame: Baseline, 8 Weeks

  3. Barthel Index

    The Barthel Index. To assess the level of independence in carrying out activities of daily living

    Time frame: Baseline, 8 Weeks

  4. Trail Making Test (TMT)

    A digital implementation of the Trail Making Test. To assess Changes in cognitive function in terms of speed of executive functions and attention

    Time frame: Baseline, 8 Weeks

  5. Corsi block-tapping test

    A digital implementation of the Corsi block-tapping test. To assess changes in working memory

    Time frame: Baseline, 8 Weeks

  6. WAIS IV - Perceptual Reasoning section (PRI)

    Perceptual Reasoning Section of the Wechsler Adult Intelligence Scale (WAIS-IV)

    Time frame: Baseline, 8 Weeks

Other outcomes

  1. Changes in brain functional connectivity, measured by fMRI

    Changes in brain functional connectivity, measured by fMRI

    Time frame: Baseline, 8 Weeks

07

Study locations

1 of 1 sites recruiting
  • Ana María Escalante-Gonzalbo
    Mexico City, Tlalpan, CDMX 14269, Mexico
    Recruiting
08

References and documents

Publications

  • Escalante-Gonzalbo AM, Ramirez-Graullera YS, Pasantes H, Aguilar-Chale JJ, Sanchez-Castillo GI, Escutia-Macedo XA, Briseno-Soriano TM, Franco-Castro P, Estrada-Rosales AL, Vazquez-Abundes SE, Andrade-Morales D, Hernandez-Franco J, Palafox L. Safety, Feasibility, and Acceptability of a New Virtual Rehabilitation Platform: A Supervised Pilot Study. Rehabil Process Outcome. 2021 Aug 7;10:11795727211033279. doi: 10.1177/11795727211033279. eCollection 2021. PubMed 34987304 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2022 (actual). Primary completion is estimated for Nov 2025, 35 months after the start.

Of 572 non-industry interventional studies with no phase under Ischemic Stroke, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 48. This study's planned 35 months is above that.

Counting every sponsor, half of 653 studies reached it within 27 months; a quarter within 14 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 23, 2022
First posted
Mar 17, 2022
StartActual
Dec 2, 2022
Primary completionEst.
Nov 2025
CompletionEst.
Nov 2025
Last update
May 7, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05283369
Lead sponsor
Universidad Nacional Autonoma de Mexico
Collaborators
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
Responsible party
Ana María Escalante Gonzalbo (Principal Investigator, Universidad Nacional Autonoma de Mexico) — Principal investigator
First posted
Mar 17, 2022
Start date
Dec 2, 2022
Primary completion
Nov 2025 (estimated)
Completion
Nov 2025 (estimated)
Last update
May 7, 2024

Study contacts

Ana María Escalante-Gonzalbo, MCompSci
Contact
aescalan@ifc.unam.mx
(52)5523397244
Yoás S Ramírez-Graullera, MCompSci
Contact
ygraullera@ifc.unam.mx
(52)5527409802
Ana María Escalante-Gonzalbo, MCompSci
principal investigator · Universidad Nacional Autonoma de Mexico

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion